TABLE 1.
Types of CT Tests Offered by Year (n = 236)
| Type of CT Test | 2013 | 2015 | ||||
|---|---|---|---|---|---|---|
| In-House, n (%) | Referral, n (%) | Not Offered, n (%) | In-House, n (%) | Referral, n (%) | Not Offered, n (%) | |
| Culture | 22 (9.3) | 170 (72.0) | 44 (18.6) | 22 (9.3) | 143 (60.6) | 69 (29.2) |
| DFA | 11 (4.7) | 120 (50.8) | 105 (44.5) | 8 (3.4) | 99 (41.9) | 127 (53.8) |
| Hybrid capture | 3 (1.3) | 82 (34.7) | 151 (64.0) | 2 (0.8) | 79 (33.5) | 153 (64.8) |
| NAAT | 130 (55.1) | 96 (40.7) | 9 (3.8) | 135 (57.2) | 93 (39.4) | 7 (3.0) |
| Rapid test | 8 (3.4) | 56 (23.7) | 172 (72.9) | 6 (2.5) | 60 (25.4) | 167 (70.8) |
| MIF | 2 (0.8) | 79 (33.5) | 155 (65.7) | 2 (0.8) | 73 (30.9) | 159 (67.4) |
| EIA | 2 (0.8) | 86 (36.4) | 148 (62.7) | 7 (3.0) | 79 (33.5) | 148 (62.7) |
| CF | 1 (0.4) | 78 (33.1) | 157 (66.5) | 0 (0.0) | 78 (33.1) | 156 (66.1) |
| Other | 4 (1.7) | 8 (3.4) | 224 (94.9) | 4 (1.7) | 19 (8.1) | 213 (90.2) |
CF indicates complement fixation; DFA, direct fluorescent antibody; EIA, enzyme immunoassay; MIF, microimmunofluorescence; NAAT, nucleic acid amplification testing;